Navigation Links
Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Date:9/5/2007

CEOs, Venture Capitalists, Medical and Media Leaders Speakers and Panels;

Live Surgeries and 'Top 10' Innovations List to be Featured

CLEVELAND, Sept. 5 /PRNewswire/ -- Cleveland Clinic will host its annual Medical Innovation Summit, an international gathering of health care, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.

The 2007 Medical Innovation Summit will feature:

-- Nationally Recognized Speakers and Panelists: Sidney Taurel, Eli

Lilly; George Buckley, 3M; Bill Hawkins, Medtronic; Stephen Hemsley,

UnitedHealth Group; Tony Zook, AstraZeneca; and many other CEOs, top

venture investors, medical leaders and network correspondents will

explore top technology issues in cardiovascular medicine including

drug-eluting stents, stem cells, personalized care, wellness,

implantable devices, and treating arrhythmias of the heart. A complete

list of speakers is available online at

http://www.clevelandclinic.org/innovations/summit/.

-- "Top 10" Health Care Innovations: Cleveland Clinic clinicians and

researchers will announce and discuss their second annual selection of

the "Top 10" medical innovations they expect to have a significant

impact in 2008.

-- Live Surgeries: Two live, interactive surgeries will illustrate state

of the art treatments for cardiovascular disease. Surgeries will be

broadcast in the Bank of America Conference Center of the

InterContinental Hotel Cleveland each morning at 7:30 a.m.

This marks the fifth year Cleveland Clinic has hosted this international gathering of industry decision-makers to dissect advances revolutionizing health care and accelerate the application of life-saving cardiovascular technologies. The 2007 Medical Innovation Summit will draw 900 industry executives, entrepreneurs, venture capitalists and clinicians. Also featured will be the Cleveland Clinic's annual selection of the "Top 10" health care innovations, live, interactive surgeries and in-depth debates on industry challenges.

For more information on the Medical Innovation Summit, including the agenda, please visit http://www.clevelandclinic.org/innovations/summit/.

CCF Innovations, the commercialization and innovation arm of Cleveland Clinic, organizes the Medical Innovation Summit, promotes innovation and is responsible for commercialization of all Cleveland Clinic technologies. CCF Innovations advances product-oriented innovation and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin- off companies, licensees and equity partnerships.

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. Approximately 1,800 full-time salaried physicians and researchers at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties. In 2006, there were 3.1 million outpatient visits to Cleveland Clinic. Patients came for treatment from every state and from more than 80 countries. There were more than 53,000 hospital admissions to Cleveland Clinic in 2006. Cleveland Clinic's Web site address is http://www.clevelandclinic.org.


'/>"/>
SOURCE Cleveland Clinic
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
2. High iron levels may cause Cardiovascular Disease in women
3. Air Pollution said To Increase Risk of Cardiovascular Disease
4. Link Between Alcohol Consumption And Cardiovascular Disease
5. Beer Found To Be Effective In Fighting Cardiovascular Disease
6. New Guidelines Found To Benefit Cardiovascular Treatment
7. Women With A High-Risk Of Cardiovascular Disease Under treated
8. People who fight wars may be at high risk of cardiovascular disease
9. Low glycemic diet effective for reducing cardiovascular risk
10. Air pollution to affect diabetes patients’ cardiovascular risks
11. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written a new ... the Bible about helping to stop cancer. Yisrayl says there are too many suffering and ... health and science industries will pay close attention and take action. The Pastor says that ...
(Date:5/6/2016)... ... ... “ Crossing Over: Affirmations of Faith in the Midst of the Dying ” ... vigil to glimpse into the supernatural as their lives ended. With her debut book, ... gain insight into providing care to terminal patients. , “I was inspired to ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... (LAIs), today announced a development collaboration with the Australian critical medicine company, ... disorders such as schizophrenia. , LAI medicines can offer improved therapeutic benefits over ...
(Date:5/5/2016)... ... , ... TLC Laser Eye Centers announced today that it has acquired Gordon ... be called “Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center.” , ... ensure that patients continue to receive the highest quality of care. In addition, all ...
(Date:5/5/2016)... ... 2016 , ... LELO has discovered many people are insecure about ... via email, social media and on the Volonté blog seeking advice about how to ... ‘normal’ or ‘correct’?” , While some methods are more common than others, there is ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 6, 2016 ... of liver disorders along with rise in obesity ... drugs in the coming few years. The NASH ... last five years on account of rising number ... is a large, un-tapped market with no FDA ...
(Date:5/5/2016)... -- , First quarter 2016 adjusted diluted ... million , First quarter reported diluted (GAAP) ... , Company revises 2016 financial guidance; now expects 2016 ... 2016 adjusted diluted non-GAAP earnings per share to range from ... regarding Generics business and manufacturing facility restructuring , ...
(Date:5/5/2016)... May 5, 2016 Research and Markets has ... in Top 5 EU Markets"  report to their offering.  ,     ... provides information on the current Positron Emission Tomography (PET) scanner ... (T5 EU), which includes France , ... Spain and the United Kingdom ...
Breaking Medicine Technology: